KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Return on Sales (2017 - 2025)

Bionano Genomics (BNGO) has disclosed Return on Sales for 9 consecutive years, with 1.0% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 152.0% to 1.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.93% through Dec 2025, up 273.0% year-over-year, with the annual reading at 0.93% for FY2025, 273.0% up from the prior year.
  • Return on Sales hit 1.0% in Q4 2025 for Bionano Genomics, up from 1.15% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.48% in Q1 2025 to a low of 12.08% in Q3 2023.
  • Historically, Return on Sales has averaged 4.01% across 5 years, with a median of 4.25% in 2022.
  • Biggest five-year swings in Return on Sales: plummeted -768bps in 2023 and later surged 613bps in 2025.
  • Year by year, Return on Sales stood at 3.64% in 2021, then fell by -29bps to 4.71% in 2022, then increased by 13bps to 4.09% in 2023, then surged by 38bps to 2.52% in 2024, then surged by 60bps to 1.0% in 2025.
  • Business Quant data shows Return on Sales for BNGO at 1.0% in Q4 2025, 1.15% in Q3 2025, and 1.02% in Q2 2025.